These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1980270)

  • 61. Clonidine in neuroleptic-induced akathisia.
    Adler LA; Angrist B; Peselow E; Reitano J; Rotrosen J
    Am J Psychiatry; 1987 Feb; 144(2):235-6. PubMed ID: 2880516
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum iron abnormalities in neuroleptic-induced akathisia in schizophrenic patients.
    Soni SD; Tench D; Routledge RC
    Br J Psychiatry; 1993 Nov; 163():669-72. PubMed ID: 7905347
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Opioid responsiveness in patients with neuroleptic-induced akathisia.
    Walters A; Hening W; Chokroverty S; Fahn S
    Mov Disord; 1986; 1(2):119-27. PubMed ID: 2904116
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Randomized, double-blind, crossover, placebo-controlled comparison of propranolol and betaxolol in the treatment of neuroleptic-induced akathisia.
    Dumon JP; Catteau J; Lanvin F; Dupuis BA
    Am J Psychiatry; 1992 May; 149(5):647-50. PubMed ID: 1349458
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Smoking and movement disorders in psychiatric patients.
    Menza MA; Grossman N; Van Horn M; Cody R; Forman N
    Biol Psychiatry; 1991 Jul; 30(2):109-15. PubMed ID: 1680470
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identifying akinesia and akathisia: the relationship between patient's self-report and nurse's assessment.
    Michaels RA; Mumford K
    Arch Psychiatr Nurs; 1989 Apr; 3(2):97-101. PubMed ID: 2565706
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nadolol as a treatment for akathisia.
    Ratey JJ; Sorgi P; Polakoff S
    Am J Psychiatry; 1985 May; 142(5):640-2. PubMed ID: 2858984
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tardive dyskinesia and positive symptoms of schizophrenia.
    White T; Brown KW; Woods JP
    Acta Psychiatr Scand; 1991 May; 83(5):377-9. PubMed ID: 1677232
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
    van Harten PN; Matroos GE; Hoek HW; Kahn RS
    Schizophr Res; 1996 May; 19(2-3):195-203. PubMed ID: 8789918
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
    Levin H; Chengappa KN; Kambhampati RK; Mahdavi N; Ganguli R
    J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of a specific beta 2-receptor blocker in neuroleptic-induced akathisia.
    Adler L; Duncan E; Angrist B; Hemdal P; Rotrosen J; Slotnick V
    Psychiatry Res; 1989 Jan; 27(1):1-4. PubMed ID: 2564208
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study.
    Lerner V; Bergman J; Statsenko N; Miodownik C
    J Clin Psychiatry; 2004 Nov; 65(11):1550-4. PubMed ID: 15554771
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Propranolol in the treatment of neuroleptic-induced akathisia (NIA) in schizophrenics: a double-blind, placebo-controlled study.
    Kramer MS; Gorkin RA; DiJohnson C; Sheves P
    Biol Psychiatry; 1988 Nov; 24(7):823-7. PubMed ID: 2906547
    [No Abstract]   [Full Text] [Related]  

  • 74. The epidemiology of drug-induced akathisia: Part II. Chronic, tardive, and withdrawal akathisias.
    Sachdev P
    Schizophr Bull; 1995; 21(3):451-61. PubMed ID: 7481575
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
    Modestin J; Wehrli MV; Stephan PL; Agarwalla P
    Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The relationship between akathisia and subjective tolerability in patients with schizophrenia.
    Kim JH; Byun HJ
    Int J Neurosci; 2010 Jul; 120(7):507-11. PubMed ID: 20583904
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cyproheptadine treatment in neuroleptic-induced akathisia.
    Weiss D; Aizenberg D; Hermesh H; Zemishlany Z; Munitz H; Radwan M; Weizman A
    Br J Psychiatry; 1995 Oct; 167(4):483-6. PubMed ID: 8829717
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Painful sensory symptoms in neuroleptic-induced extrapyramidal syndromes.
    Decina P; Mukherjee S; Caracci G; Harrison K
    Am J Psychiatry; 1992 Aug; 149(8):1075-80. PubMed ID: 1353315
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study.
    Miodownik C; Lerner V; Statsenko N; Dwolatzky T; Nemets B; Berzak E; Bergman J
    Clin Neuropharmacol; 2006; 29(2):68-72. PubMed ID: 16614537
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacological characterization of tardive akathisia.
    Sachdev P; Chee KY
    Biol Psychiatry; 1990 Nov; 28(9):809-18. PubMed ID: 1979500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.